MFS
CLVS

Mirabella Financial Services’s Clovis Oncology, Inc. CLVS Stock Holding History

Mirabella Financial Services’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-17,600
Closed -$36K – 780
2022
Q1 		$36K Buy
+17,600
New +$34.6K ﹤0.01% 503
2020
Q4 		– Sell
-25,680
Closed -$150K – 525
2020
Q3 		$150K Buy
+25,680
New +$154K 0.02% 306

Other funds holding CLVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return

Mirabella Financial Services's CLVS Position: Q2 2022 in Review

Mirabella Financial Services sold out of Clovis Oncology, Inc. (CLVS) in Q2 2022, closing a stake of 17,600 shares — an estimated $36K sold.

Mirabella Financial Services first reported a position in CLVS in Q3 2020 and held it in 2 quarters. The position peaked at $150K in Q3 2020. 115 funds tracked by Wall St. Rank hold CLVS as of Q2 2022.

  • Mirabella Financial Services reported no remaining Clovis Oncology, Inc. position as of Q2 2022 after selling out during the quarter.
  • Mirabella Financial Services sold 17,600 Clovis Oncology, Inc. shares in Q2 2022, an estimated $36K.
  • Mirabella Financial Services first reported a position in Clovis Oncology, Inc. in Q3 2020 and held it in 2 quarters.
  • Mirabella Financial Services's Clovis Oncology, Inc. position peaked at $150K in Q3 2020.
  • 115 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q2 2022.

Based on Mirabella Financial Services's 13F filing for Q2 2022, filed 12 Aug 2022.